Navigation Links
Sosei Confirms the Safety of SD118 in Two Phase I Trials
Date:12/8/2008

sei.com

About NeuroDiscovery

NeuroDiscovery Ltd is an ASX listed speciality neuroscience services provider and drug development company which owns 100% of NeuroSolutions Ltd (ASX Code NDL).

About NeuroSolutions

NeuroSolutions Limited is a profitable service company, which has applied its broad spectrum expertise and drug discovery platforms to become a leading provider of specialised electrophysiological assays to the biopharmaceutical industry. Electrophysiology is a specialised technique which is used to record electrical activity in membranes, cells or tissues. NeuroSolutions' current clients include many established pharmaceutical and biotechnology companies.

In parallel to running its service business, the Company is also exploiting its in-house technologies and expertise for its own internal R&D and has a mature pipeline of programmes underway for the treatment of pain.

During 2008, the Company reported success in a Phase II trial for NSL-101. The Company also successfully completed two Phase I trials for the development compound NSL-043/SD118, in partnership with Sosei Co. Ltd. Both of these trials reported a successful outcome, facilitating further development.


'/>"/>
SOURCE Sosei Group Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting
2. Sosei Announces Completion of Phase III Trial for NorLevo(R)
3. National Study Presented at ACG 2008 Confirms New Device Functions Like Rear-View Mirror to Provide Improved View of the Colon
4. Novo Nordisk New Data From a Phase 3 Study Confirms Clinical Benefits of Once-Daily Liraglutide in the Management of Type 2 Diabetes
5. Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A
6. New Meta-Analysis Confirms Safety Profile for NeoRecormon in Treating Anaemia in Cancer Patients
7. New Data From Head-to-Head Study Confirms Once-Daily Levemir(R) is as Effective as Glargine over a 24-Hour Period in Subjects with Type 2 Diabetes
8. University of Miami Team Confirms Value of Monitoring Cell-Mediated Immunity Pre- and Post-Transplant in Management of Kidney Transplant Recipients
9. Study Confirms That Avastin Significantly Increases Chance of Living Without Disease Progression in Metastatic Breast Cancer
10. AviaraDx Confirms That Combination of Two Molecular Biomarkers Improves Prediction of Disease Recurrence in Early Stage Breast Cancer Patients
11. New Study Confirms Dose-Accuracy of SoloSTAR(R) Prefilled Insulin Pen

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)..., ,, ANDOVER,Mass.,Nov.24/PRNewswire/--Vis...edicusLtd.(ASX:PME),willbeintroducingVisage®7...ion,attheAnnualConferenceoftheRadiologicSocietyofN...ago,IL. ,, Visage®7deliversnewlevelsofvers...sub-specialists,andreferringphysicians.TheVisage7U...
(Date:11/24/2009)..., NEWYORK,Nov.24/PRNewswire-FirstCall/--KeryxBio...hatRonBentsur,theCompany,sChiefExecutiveOfficer,is...hCareConferencebeingheldinNewYorkCity. ,, Mr.Be...cember2ndat10:30AMETandwillbeaccessiblefromtheInve...investors.keryx.com .Anarchivedversionofthewebcast...
(Date:11/23/2009)..., CHICAGO,Nov.23/PRNewswire/--TwooftheChicagoare...ntroducinganewerainwomen,sbreastimaging,couplingth...nddiagnosticultrasoundwiththeabilitytohavethefullr...dwiththepatientbeforesheleavestheoffice.Drs.AhmedF...approach,withoutthecurrent6-9monthwaitforanappoint...
Breaking Medicine Technology:Visage Imaging Introduces Visage(R) 7 for Windows and Mac OS X 2Keryx Biopharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Glenmarks Novel Molecule for Diabetes Melogliptin to Enter Phase III Trials 12766 1Glenmarks Novel Molecule for Diabetes Melogliptin to Enter Phase III Trials 12766 2Team Full Throttle Twinlab 28R 29 Racing Nabs Podiums in Several Divisions at the 2009 Robert J Aaron Memorial Mighty Montauk Triathlon 49915 1Team Full Throttle Twinlab 28R 29 Racing Nabs Podiums in Several Divisions at the 2009 Robert J Aaron Memorial Mighty Montauk Triathlon 49915 2Attorney General Holder HHS Secretary Sebelius and FBI Director Mueller Announce Law Enforcement Action Related to Heat Task Force 49911 1
...ed Unlike What Is Commonly Seen In,Insulin Therapy... Novo Nordisk,today announced results of a new stu...cy of insulin Levemir(R) (insulin detemir,[rDNA or...re able,to adjust their own dosage of Levemir(R) a... to dosing adjusted by their primary care,physicia...
...20-50% Improvement in Post-Preservation,Functional...r,Therapy, BOTHELL, Wash., June 25, 2007 /PRNewswi...g developer and marketer of proprietary,hypothermi...cells,tissues, and organs, today presented data f... cryopreservation media at the annual,meeting of t...
Other Medicine Technology:New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes,Using Self-Adjusted Dosing Starting With Once-Daily Insulin,Treatment Levemir 2New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes,Using Self-Adjusted Dosing Starting With Once-Daily Insulin,Treatment Levemir 3New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes,Using Self-Adjusted Dosing Starting With Once-Daily Insulin,Treatment Levemir 4New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes,Using Self-Adjusted Dosing Starting With Once-Daily Insulin,Treatment Levemir 5BioLife Solutions Presents Data on CryoStor at International,Society for Cellular Therapy Annual Meeting 2BioLife Solutions Presents Data on CryoStor at International,Society for Cellular Therapy Annual Meeting 3BioLife Solutions Presents Data on CryoStor at International,Society for Cellular Therapy Annual Meeting 4
(Date:11/24/2009)...eeded when taking sedatives, antidepressants, benz...ov. 24 (HealthDay News) -- Seniors who take antide...tions may be at increased risk for falls, a new re...published studies that included a total of 79,081 ...nine classes of drugs: high blood pressure medicin...
(Date:11/24/2009)...ANTACLARA,Calif.,Nov.24/PRNewswire/--AgitoNetworks...erprisemobility,todayannouncedthatitwashonoredinth...AgitoRoamAnywhereMobilityRouterv3.0.EverythingChan...thathaveintroducednewsolutionsthatdriveadvancesthr...el,sTestCenterreviewedhundredsofapplicationsforthe...
(Date:11/24/2009)...ASHINGTON,Nov.24/PRNewswire/--TheUnionLaborLifeIns...thasalignedwithVSP(®),()thenation,slargestvis...ioninsuranceproductstounions,uniontrustfunds,union...accesspointsofferingservicesincludingcomprehensive...understandhowimportantqualityeyecareis,"statedBruc...
(Date:11/24/2009)...ds that quitting improves heart prospects, but can...ealthDay News) -- A new study offers yet more proo...om heart disease and cancer. , Researchers foll...smokers, formers smokers and nonsmokers for three ... times more likely to die of cancer, 2.26 times mo...
(Date:11/24/2009)...ix as an example, study finds no added use but hig...y News) -- Direct-to-consumer drug ads may contrib...tudy that examined sales of the widely used antipl...s of data from 1999 to 2005 for 27 state Medicaid ... for clopidogrel did not increase people,s use of ...
Breaking Medicine News(10 mins):Health News:Some Prescription Meds May Raise Seniors' Risks of Falling 2Health News:Agito Networks Recognized in the 2009 Tech Innovators Awards Program by Everything Channel 2Health News:Agito Networks Recognized in the 2009 Tech Innovators Awards Program by Everything Channel 3Health News:Union Labor Life & VSP Vision Care Align to Offer Vision Insurance Products 2Health News:Smokers Double Their Risk for Heart Disease 2Health News:Advertising to Consumers May Raise Drug Prices 2
...ery disease the single leading cause of death in t...atients as a prevention and treatment regiment for...te on the effectiveness of aspirin, researchers at...tients with heart disease. Most coronary arte...
... Lung and Blood Institute (NHLBI) Working Group fi...enefits of treating depression// in their patients...nd treatment for it. The report is published in "A...rican Psychiatric Association's criteria for major...
...n the brains of vertebrates and fruit fly denote w... these visual maps// that need to be wired properl...lt stage. A general notion is that visual maps are... the journal Current Biology, Drs. P. Robin Hiesin...
...ecalling its dietary supplementary product after t...is an analogue of sildenafil, the active pharmaceu... the treatment of erectile dysfunction and it is e...nd their blood pressure lowered suddenly. The FDA ...
...Dairy, South of Fresno, is going through a rough p... products.// The ban was enforced after three chil... E.Coli contamination. The dairy owner refuti...epartment of Food and Agriculture while confirming...
...people die of coronary diseases in India annually ... next 10 years due to loss in productive working d...rently India is home to over 60 million coronary h...han spoke on the eve of World Heart Day Sunday. ...
Other Medicine News:Health News:Heart Center at Sinai Conducts Landmark Study on Aspirin Resistance 2Health News:Cardiologists Ignoring Treatment Of Depression 2Health News:Fruit fly’s visual map based entirely on genetic inputs 2Health News:India may Lose Over $230 bn from Heart Diseases 2
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
Medicine Products: